MIRA INFORM REPORT

 

 

Report No. :

351761

Report Date :

30.11.2015

 

IDENTIFICATION DETAILS

 

Name :

HETERO LABS LIMITED (w.e.f. 07.06.2001)

 

 

Formerly Known As:

HETERO LABS PRIVATE LIMITED (w.e.f. 30.05.1997)

 

PHARMASIA LABORATORIES PRIVATE LIMITED (w.e.f 30.12.1992)

 

PERMILA DRUGS PRIVATE LIMITED

 

 

Registered Office :

7-2-A2, Hetero Corporate Industrial Estate, Sanathnagar, Hyderabad – 500018, Telangana

Tel No.:

91-40-23704923

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

10.03.1989

 

 

Com. Reg. No.:

01-009723

 

 

Capital Investment / Paid-up Capital :

Rs. 13.320 Million

 

 

CIN No.:

[Company Identification No.]

U24110TG1989PLC009723

 

 

IEC No.:

0997003006

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAACH5506R

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Subject is primarily engaged in the manufacturing of APIs and finished dosages formulations (FDF).

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (70)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 4300000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Exist

 

 

Comments :

Subject was incorporated in 1989 and it is the flagship company of the Hetero group. The company is a pharmaceutical company primarily engaged in the manufacturing of APIs and finished dosages formulations (FDF).

 

For the financial year ended 2014, company has reported 36.41% sales turnover growth as compared to previous sales turnover and it has maintained decent profitability margins at 10.12% during the year under a review.

 

Rating continue to draw strength from the fact that the company is a part of the Hetero group, the promoters rich experience in pharmaceutical business, strong products portfolio of formulations and active pharmaceutical ingredients.

 

Rating also takes into consideration company’s healthy financial profile marked by strong networth base along with healthy debt coverage indicators and sound liquidity positions

 

Rating strength is partially offset by working capital intense nature of business operations and highly fragmented industry with many unorganized players.

 

 

Trade relations are reported as fair. Payments are reported to be regular and as per commitment.

 

The company can be considered good for normal business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CARE

Rating

Long Term Bank Facility = A+

Rating Explanation

Adequate degree of safety and low credit risk.

Date

03.12.2014

 

 

Rating Agency Name

CARE

Rating

Short Term Bank Facility = A1

Rating Explanation

Very Strong degree of safety and low credit risk.

Date

03.12.2014

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2015.

 

LOCATIONS

 

Registered Office :

7-2-A2, Hetero Corporate Industrial Estate, Sanathnagar, Hyderabad – 500018, Telangana, India

Tel. No.:

91-40-23704923

Fax No.:

91-40-23704923/23714250

E-Mail :

contact@heterodrugs.com

ramu@heterodrugs.com

vasucs@heterodrugs.com

sambhram.p@heterodrugs.com

Website :

http://www.heterodrugs.com

 

 

Factory:

Located at:

  • Hyderabad
  • Gundlamachanoor

 

 

Marketing Office:  :

Located at:

  • United State of America
  • Russia
  • Europe
  • China
  • Thailand
  • UAE
  • Egypt
  • South Africa

 

 

DIRECTORS

 

As on 25.09.2014

 

Name :

Dr. Bandi Partha Saradhi Reddy

Designation :

Managing Director

Address :

Plot No. 389, Road No. 22/B, Jublihills Chequepost, Madhapoor Road, Hyderabad – 500038, Telangana, India

Date of Birth/Age :

06.03.1954

Qualification :

PHD in Organic Chemistry

Date of Appointment :

01.11.2011

DIN No.:

00015899

PAN No.:

AAJPB7067K

 

Name :

Mr. Vamsikrishna Bandi

Designation :

Whole-time director

Address :

Plot No.389, Road No.22/B, Jubilee Hills, Check-Post, Hyderabad-500033, Telangana, India

Date of Birth/Age :

31.07.1983

Date of Appointment :

01.05.2011

DIN No.:

01014619

PAN No.:

AIPPB1881R

 

Name :

Mr. Attunuri Venkata Narasa Reddy

Designation :

Whole-time director

Address :

H. No. 8-3-678/61, Pragathi Nagar Colony, Yosufguda, Hyderabad – 500018, Telangana, India

Date of Birth/Age :

21.12.1963

Date of Appointment :

11.03.1999

DIN No.:

00023432

 

Name :

Mr. Mohan Reddy Chilukuri

Designation :

Whole Time Director

Address :

Plot No.54, Green Avenue, Nizampet Road, Nizampet, Hyderabad – 500000, Telangana, India

Date of Birth/Age :

02.01.1969

Date of Appointment :

01.04.2012

DIN No.:

00208921

 

 

Name :

Mr. Srinivas Reddy Male

Designation :

Director

Address :

8-2-293/82/NL/138, Road No.10C, Plot No.138/139, MP/MLA Colony, Jubilee Hills, Hyderabad - 500033, Telangana, India

Date of Birth/Age :

02.02.1973

Qualification :

MBA. Marketing

Date of Appointment :

01.08.2013

DIN No.:

00016085

 

Name :

Mr. Rathnakar Reddy Kura

Designation :

Director

Address :

Villa No.148, Indu Fortune Fields, 13th Phase, KPHB Colony, Hyderabad - 500072, Telangana, India

Date of Appointment :

02.06.2014

DIN No.:

00211510

 

 

Name :

Mr. Gopal Reddy Annareddy

Designation :

Additional Director

Address :

8-2-293/82/JIII/511, Phase - III, Road No.86, Jubilee Hills, Hyderabad - 500033, Telangana, India

Date of Appointment :

08.10.2015

DIN No.:

07306495

 

Name :

Ms. Kalavathi Bandi

Designation :

Additional Director

Address :

Plot No-389,Road No 22-B, Jubilee Hills, Hyderabad - 500033, Telangana, India

Date of Appointment :

01.04.2015

DIN No.:

00194597

 

 

Name :

Mr. Rajasekhara Reddy

Designation :

Additional Director

Address :

Flat No B - 02, MCH No 8-2-416, Stone Valley Apartments, Road No 4, Banjara Hills, Hyderabad, 500034, Telangana, India

Date of Appointment :

12.06.2015

DIN No.:

02339668

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 25.09.2014

 

Names of Shareholders

No. of Shares

%age

B. Partha Saradhi Reddy

282860

21.24

M. Srinivas Reddy

200

0.02

B. Kalavathi

160740

12.07

M. Krishna Sindhuri

150000

11.26

B. Vamsi Krishna

398000

29.88

B. Soma Kantham

200

0.02

M. Krishna Karthikeya Reddy

146900

11.03

B. Srinivasula Reddy

200

0.02

B. Anvida

46000

3.45

M. Krishna Sahithi

146900

11.03

Total

1332000

100.00

 

 

 

As on 25.09.2014

 

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is primarily engaged in the manufacturing of APIs and finished dosages formulations (FDF).

 

 

Products :

Product Description

Item Code No. (ITC Code)

Pharmaceuticals Formulation

30065000

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Available

 

 

Imports :

Not Available

 

 

Terms :

Not Available

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Available

Name of the Person :

Not Available

Contact No.:

Not Available

Since How Long Known :

Not Available

Maximum Limit Dealt :

Not Available

Experience :

Not Available

Remark:

Not Available

 

 

Customers :

Reference :

Not Available

Name of the Person :

Not Available

Contact No.:

Not Available

Since How Long Known :

Not Available

Maximum Limit Dealt :

Not Available

Experience :

Not Available

Remark:

Not Available

 

 

No. of Employees :

Not Available

 

 

Bankers :

Banker Name

Bank of India

Branch Address

Hyderabad Large Corporate Branch, 10-1-1199/2, 1st Floor, P.T.I. Building, A.C. Guards, Masab Tank, Hyderabad – 500004, Telangana, India

Person Name (With Designation)

Not Available

Contact Number

Not Available

Name of Account Holder

Not Available

Account Number

Not Available

Account Since (Date/Year of Account Opening)

Not Available

Average Balance Maintained (If Possible)

Not Available

Credit Facilities Enjoyed (If any)

Not Available

Account Operation

Not Available

Remarks (If any)

Not Available

 

 

Facilities :

(Rs. In Million)

SECURED LOAN

As on

31.03.2014

As on

31.03.2013

LONG TERM BORROWING

 

 

Rupee From Loans From Bank

2015.957

1452.051

Foreign Currency Term Loans From Bank

1515.567

2107.542

SHORT TERM BORROWING

 

 

Working Capitals Loan From Bank

9394.383

8065.918

 

 

 

Total

12925.907

11625.511

 

Auditors :

 

Name :

M. V. Narayana Reddy and Company

Chartered Accountants

Address :

D. No. 8-3-941, Flat No. 504, Vijayasree Apartments, Opposite Kamma Sangham, Ameerpet, Hyderabad – 50007, Telangana, India

Tel. No.:

91-40-23743975 / 23744448

PAN No.:

AADFM4830F

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Enterprises which are

owned, or have significant

influence of or are partners

with Key management

personnel and their relatives :

  • Cirex Pharmaceuticals Limited
  • Clinse Labs Private Limited
  • Genx Pharma Limited
  • Hetero Drugs Limited
  • Hetero Healthcare Limited
  • Symed Labs Limited
  • Chemi Pack (India) Private Limited
  • Hetero Med Solutions Limited
  • Camber Pharmaceuticals Inc
  • Invagen Pharmaceuticals Inc
  • Hetmak Fzco
  • Akar International Fzc
  • Mint Pharmaceuticals Inc Honour Lab Limited

 

 

Subsidiary company

  • Hetero Fzco
  • Hetero Wind Power Limited

 

 

Joint venture

  • Pharmed Healthcare

 

 

Fellow Subsidiary company

  • Hetlabs Mexico

 

 

Associates :

  • Hetero Infrastructure Sez Limited
  • Hetero (Thailand) Limited
  • Hetero Singapore Pte Limited
  • Hetero Usa Inc
  • Hetero Europe SL
  • Arapharma Group S A

 

 

CAPITAL STRUCTURE

 

As on 31.03.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1500000

Equity Shares

Rs.10/- each

Rs.15.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1320000

Equity Shares

Rs.10/- each

Rs.13.320 Million

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

13.320

13.320

13.320

(b) Reserves & Surplus

15193.981

11449.970

9651.664

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

15207.301

11463.290

9664.984

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

3531.524

3559.593

2768.186

(b) Deferred tax liabilities (Net)

1199.897

1071.107

735.668

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

95.243

74.408

49.947

Total Non-current Liabilities (3)

4826.664

4705.108

3553.801

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

10090.177

9435.509

7778.435

(b) Trade payables

4753.913

4808.864

3973.460

(c) Other current liabilities

3085.584

2563.013

1740.905

(d) Short-term provisions

126.594

110.383

78.292

Total Current Liabilities (4)

18056.268

16917.769

13571.092

 

 

 

 

TOTAL

38090.233

33086.167

26789.877

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

10448.326

9919.285

7789.060

(ii) Intangible Assets

68.965

17.902

21.693

(iii) Capital work-in-progress

2845.841

1477.437

2373.585

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

1004.939

888.107

391.607

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

922.041

1100.254

1019.898

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

15290.112

13402.985

11595.843

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

8998.963

9310.699

7382.000

(c) Trade receivables

11916.555

9287.242

6686.970

(d) Cash and cash equivalents

321.995

189.818

230.974

(e) Short-term loans and advances

638.051

57.225

68.188

(f) Other current assets

924.557

838.198

825.902

Total Current Assets

22800.121

19683.182

15194.034

 

 

 

 

TOTAL

38090.233

33086.167

26789.877

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

Income

37301.511

27605.375

20381.480

 

Other Income

752.562

291.542

47.902

 

 

TOTAL                                    

38054.073

27896.917

20429.382

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

22096.168

14987.593

13605.379

 

Purchases of Stock-in-Trade

116.785

457.716

344.046

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(262.222)

746.356

(1905.333)

 

Employees benefits expense

1975.151

1466.736

980.549

 

Other expenses

6886.758

5541.959

3786.144

 

 

TOTAL                                    

30812.640

23200.360

16810.785

 

 

 

 

 

Less

PROFIT/(LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

7241.433

4696.557

3618.597

 

 

 

 

 

Less

FINANCIAL EXPENSES                                   

1683.453

1465.230

870.778

 

 

 

 

 

 

PROFIT/(LOSS)  BEFORE TAX, DEPRECIATION AND AMORTISATION

5557.980

3231.327

2747.819

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

585.846

524.330

398.001

 

 

 

 

 

 

PROFIT/(LOSS)  BEFORE TAX

4972.134

2706.997

2349.818

 

 

 

 

 

Less

TAX                                                                 

1198.262

878.713

749.832

 

 

 

 

 

 

PROFIT/(LOSS) AFTER TAX

3773.872

1828.284

1599.986

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

F.O.B. Value of Exports

25148.290

16929.380

NA

 

TOTAL EARNINGS

25148.290

16929.380

NA

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Materials

10772.060

7644.620

NA

 

Capital Goods

497.920

139.600

NA

 

TOTAL IMPORTS

11269.98

7784.22

NA

 

 

 

 

 

 

Earnings/(Loss) Per Share (Rs.)

2833.24

1372.51

1201.19

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2014

31.03.2013

31.03.2012

Current Maturities of Long term debt

1517.542

1157.742

NA

Cash generated from operations

NA

NA

NA

Net cash flows from (used in) operations

4702.074

1515.6,66

NA

Net cash flow from operating activity

3644.081

987.890

NA

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT/Sales)

(%)

10.12

6.62

7.85

 

 

 

 

 

Operating Profit Margin

(PBDIT / Sales)

(%)

19.41

17.01

17.75

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

14.52

8.81

9.78

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.33

0.24

0.24

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.90

1.13

1.09

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.26

1.16

1.12

 

 

 

 

 

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

13.320

13.320

13.320

Reserves & Surplus

9651.664

11449.970

15193.981

Net worth

9664.984

11463.290

15207.301

 

 

 

 

long-term borrowings

2768.186

3559.593

3531.524

Short term borrowings

7778.435

9435.509

10090.177

Total borrowings

10546.621

12995.102

13621.701

Debt/Equity ratio

1.091

1.134

0.896

 

 

 

 

 

 

 

YEAR-ON-YEAR GROWTH

 

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

20381.480

27605.375

37301.511

 

 

35.443

35.124

 

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

20381.480

27605.375

37301.511

Profit

1599.986

1828.284

3773.872

 

7.85%

6.62%

10.12%

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

No

8

Designation of contact person

No

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

yes

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

LITIGATION DETAILS

 

ITTA 92/2015

ITTASR 403/2015

Case Status : Pending

PETTIONER

THE PR COMMISSIONER OF INCOM TAX (CENTRAL)

RESPONDENT

VS HETERO LABS LIMITED

Pet’s Adv:-

PRASAD (SC FOR INCOME TAX)

Resp. Adv.:

HARI

SUBJECT :

U/Sec. 143 Assessment

DISTRICT

HYDERABAD

FILLING DATE :

10.03.2015

POSTING STAGE :

FOR ADMISSION AND HEARING

REG. DATE

15.06.2015

LISTING DATE

02.07.2015

STATUS

ADMIT

HON’BLE JUDGE (S)

G. CHANDRAIAH CHALLA KODANDA RAM

 

NOTE : The Registered office of the company has been shifted from H .NO. 8-3-166/1 AND 2 Challa Estates, First Floor, Erragadda, Hyderabad – 500018, Andhra Pradesh, India to the present address (w.e.f 31.07.2009)

 

UNSECURED LOAN

 

                                                                                                                                                 (Rs. In Million)

Particulars

As on

31.03.2014

As on

31.03.2013

SHORT TERM BORROWING

 

 

Loans Repayable On Demand From Bank

695.794

1369.591

Total

695.794

1369.591

 

 

 

 

 

 

 

 

 

REVIEW OF PERFORMANCE :

 

The Company has recorded its highest ever revenue of Rs.38054.070 Million. Earnings before Interest, Tax, Depreciation and Amortisation (EBIDTA) recorded a growth of 56.93 % to reachRs. 7370.370 Million. and Profit After Tax (PAT) grew to Rs.3773.870 Million. recording a growth of 106.41 % over Rs. 1828.310 Million. achieved in the previous year. Reduction in Raw material consumption due to improved production process and cycle time, Lower overhead costs, has increased the profitability. Exports increased to Rs. 25940.400 Million as compared to Rs. 17738.270 Million. in the previous year registering an export growth of 46.24%. Increase in exports sales is on account of approval of product registrations already filed in earlier years.

 

The Company's APIs business increased to Rs 9638.810 Million. During the fiscal, compared to Rs9357.540 Million. During 2012-13 registering a growth of 3.01%. API Segment Exports increased to Rs.5148.11 Million. As compared to Rs.4306.21 Million. In the previous year registering an export growth of 20%.

 

The Company's formulation business increased to Rs. 28166.520 Million. During the fiscal, compared to Rs. 18712.250 Million. During 2012-13. Formulation revenues were higher by 50.19% over the previous year on account of increase in formulation operations. Formulation Segment Exports increased to Rs20792.28 Million. As compared to Rs.13432.06 Million. In the previous year registering an export growth of 35.4%

 

 

FINANCE

 

The Company incurred finance cost of Rs.1812.390 Million during the year which is 24% higher than the previous year on account of increase in volume of operations and costs as well as higher cost of borrowings together with depreciation of rupee against major currencies.

 

The Company has repaid term loans of Rs.1146.100 Million during the year and availed fresh term loans of Rs.1261.100 Million to part finance capital expenditure during the year. The total term loans of the Company stood at Rs.5049.070 Million as on March 31, 2014.

 

 

OUTLOOK

 

Hetero during the past 4 years has developed assets for growth. People, products, Infrastructure and improved relationship with some of the big pharma Companies across the globe are the key drivers for growth of the Company. The Company is perceived as preferred and reliable supplier by its customers.

 

 The order flow remains encouraging and is being met with improved manufacturing efficiencies of pharmaceutical formulations, intermediates and Active Pharmaceuticals ingredients through process improvement and development.

 

Hetero is working to improve manufacturing process, optimize costs, reduce waste and operational expenditure, increase cash flow, rationalize manpower, protect margins, report positive earnings and risk the business.

 

INDEX OF CHARGES

 

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10478286

21/01/2014

2,126,200,000.00

BANK OF INDIA

HYDERABAD LARGE CORPORATE BRANCH,10-1-1199/2, 1ST FLOOR, P.T.I.BUILDING, A.C.GUARDS, MASAB TANK, HYDERABAD- 500004, TELANGANA, INDIA

B96678909

2

10467942

19/12/2013

1,200,000,000.00

EXPORT-IMPORT BANK OF INDIA

CENTRE ONE BUILDING, FLOOR 21, WORLD TRADE CENTRE COMPLEX, CUFFE PARADE, MUMBA- 400005I, MAHARASHTRA, INDIA

B92651371

3

10461509

28/10/2013

1,257,000,000.00

DBS Bank Limited

SALARPURIA WINDSOR, NO.3, ULSOOR ROAD, BENGALURU- 560042, 
KARNATAKA, INDIA

B90049834

4

10421516

26/12/2013 *

4,186,400,000.00

State Bank of India

INDUSTRIAL FINANCE BRANCH, RAJBHAVAN ROAD, SOMAJ 
IGUDA, HYDERABAD- 500082, TELANGANA, INDIA

B94525177

5

10308989

14/09/2011

250,000,000.00

STATE BANK OF MYSORE

INDUSTRIAL FINANCE BRANCH, MY HOME JUPALLY, AMEERPET, HYDERABAD- 500038, TELANGANA, INDIA

B22035851

6

10283954

28/09/2013 *

9,315,000,000.00

ANDHRA BANK

SPECIALIZED CORPORATE FINANCE BRANCH, 6-3-648,3RD 
FLOOR,PADMAJA LAND MARK, SOMAJIGUDA, HYDERABAD- 500082, TELANGANA, INDIA

B87173050

7

10283970

26/03/2011

500,000,000.00

ANDHRA BANK

SPECIALISED CORPORATE FINANCE BRANCH, 3RD FLOOR, 
PADMAJA LAND MARK, HYDERABAD- 500082, TELANGANA, INDIA

B12030003

8

10273568

29/12/2011 *

1,000,000,000.00

EXPORT-IMPORT BANK OF INDIA

CENTRE ONE BUILDING, FLOOR 21, WORLD TRADE CENTR 
E, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA

B28834844

9

10257057

07/12/2010

500,000,000.00

ANDHRA BANK

SPECIALISED CORPORATE FINANCE BRANCH, 3RD FLOOR, 
PADMAJA LAND MARK, SOMAJIGUDA, HYDERABAD- 500082, TELANGANA, INDIA

B01508654

10

10257800

16/11/2010

500,000,000.00

STATE BANK OF HYDERBAD

SANATHNAGAR BRANCH, INDUSTRIAL ESTATE, SANATHNAGA 
R, HYDERABAD, ANDHRA PRADESH - 500018, INDIA

B00572214

 

FIXED ASSETS

 

  • Land and Site Development
  • Factory Building
  • Electrical Equipment
  • R and D Equipment
  • ETP Machinery
  • Furniture and Fixture
  • Office Equipments
  • Vehicles
  • Computers 

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.66.75

UK Pound

1

Rs.100.67

Euro

1

Rs.70.87

 

 

INFORMATION DETAILS

 

Information Gathered by :

SVA

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

RKI


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

8

PAID-UP CAPITAL

1~10

8

OPERATING SCALE

1~10

8

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

8

--PROFITABILITY 

1~10

8

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

7

--RESERVES

1~10

8

--CREDIT LINES

1~10

8

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

70

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.